Targeted Oncology

FDA Fast Tracks PET Diagnostic Agent for Clear Cell Renal Cell Carcinoma

DPI-4452 targets CAIX in tumors, offering noninvasive diagnostic potential for ccRCC with favorable tolerability. The agent is part of a theranostic pair wi ...